Teva Pharmaceutical Industries (WBO:TEVA) Other Operating Expense : €32 Mil (TTM As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Teva Pharmaceutical Industries Other Operating Expense?

Teva Pharmaceutical Industries's Other Operating Expense for the three months ended in Jun. 2024 was €-0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was €32 Mil.

Teva Pharmaceutical Industries's quarterly Other Operating Expense declined from Dec. 2023 (€39 Mil) to Mar. 2024 (€1 Mil) and declined from Mar. 2024 (€1 Mil) to Jun. 2024 (€-0 Mil).

Teva Pharmaceutical Industries's annual Other Operating Expense stayed the same from Dec. 2021 (€-0 Mil) to Dec. 2022 (€-0 Mil) but then increased from Dec. 2022 (€-0 Mil) to Dec. 2023 (€0 Mil).

Teva Pharmaceutical Industries Other Operating Expense Historical Data

The historical data trend for Teva Pharmaceutical Industries's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Other Operating Expense Chart

Teva Pharmaceutical Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

Teva Pharmaceutical Industries Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Operating Expense	Get a 7-Day Free Trial															-	-8.43	39.43	0.92	-

Teva Pharmaceutical Industries Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €32 Mil.

Teva Pharmaceutical Industries Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Teva Pharmaceutical Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (WBO:TEVA) » Definitions » Other Operating Expense

Traded in Other Exchanges

TEVJF:USA TEVA:USA TEVA:Mexico TEVA:Israel 0LER:UK TEV:Germany TEV:Germany TEV:Germany T1EV34:Brazil TEV:Bulgaria

Address

124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020

Website

https://www.tevapharm.com

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.